Education
About Us
Working with TipRanks
Follow Us
David Brookes Insider Profile
4 Followers
David Brookes, Chairman at Anatara Lifesciences Ltd, holds 29.00M shares in Tali Digital (Ticker: DE:UV7), holds 7.40M shares in Dominion Minerals Limited (Ticker: DE:1TT), holds 6.53M shares in Anatara Lifesciences Ltd (Ticker: AU:ANR). Most recently, David Brookes Bought ― shares of Tali Digital on Jul 11, 2025 for an estimated value of 7.36K.
David Brookes Anatara Lifesciences Ltd (ANR)Chairman
Anatara Lifesciences Ltd (ANR)
Chairman
Ranked #10,592 out of 102,596 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
+24.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Brookes holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 04, 2024 - Apr 04, 2025
Return:+174.10%
The most profitable trade made by David Brookes
David Brookes's Trading History
Anatara Lifesciences Ltd
Dec 24, 2024
Chairman
Informative Buy
25.00K
AU$71.83K
Tali Digital
Jul 11, 2025
Director
Informative Buy
7.36K
―
Island Pharmaceuticals Ltd
Apr 04, 2024
Director
Informative Buy
2.40K
AU$21.00K
Dominion Minerals Limited
Jun 05, 2025
Director
Informative Buy
75.00K
€103.62K
List of latest transactions for each holding click on a transaction to see David Brookes's performance on stock
You May Also Like
David Brookes insider profile FAQ
What is the percentage of profitable transactions made by David Brookes?
The percentage of profitable transactions made by David Brookes is 38%.
What is the average return per transaction made by David Brookes?
The average return per transaction made by David Brookes is 24.00%.
What stocks does David Brookes hold?
David Brookes holds: AU:ANR, DE:UV7, AU:ILA, DE:1TT stocks.
What was David Brookes’s latest transaction?
David Brookes latest transaction was an Informative Buy of €7.36K.
What was David Brookes's most profitable transaction?
David Brookes’s most profitable transaction was an Informative Buy of AU:ILA stock on April 4, 2024. The return on the trade was 174.10%.
What is David Brookes's role in Anatara Lifesciences Ltd?
David Brookes's role in Anatara Lifesciences Ltd is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.